Cargando…

O10.5. CLINICAL HIGH RISK (CHR) CRITERIA IN CHILDREN AND ADOLESCENTS NOT SUSPECTED TO DEVELOP PSYCHOSIS: NO TRANSDIAGNOSTIC SEVERITY MARKER OF MENTAL HEALTH PROBLEMS

BACKGROUND: Compared to adults, children and adolescents of the community more frequently report clinical high risk of psychosis (CHR) criteria. Yet, little is known about the prevalence of CHR criteria in clinical children and adolescents’ samples. Thus, we studied the prevalence of CHR criteria an...

Descripción completa

Detalles Bibliográficos
Autores principales: Schultze-Lutter, Frauke, Michel, Chantal, Schimmelmann, Benno G, Franscini, Maurizia, Traber-Walker, Nina, Walger, Petra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233916/
http://dx.doi.org/10.1093/schbul/sbaa028.059
_version_ 1783535643353153536
author Schultze-Lutter, Frauke
Michel, Chantal
Schimmelmann, Benno G
Franscini, Maurizia
Traber-Walker, Nina
Walger, Petra
author_facet Schultze-Lutter, Frauke
Michel, Chantal
Schimmelmann, Benno G
Franscini, Maurizia
Traber-Walker, Nina
Walger, Petra
author_sort Schultze-Lutter, Frauke
collection PubMed
description BACKGROUND: Compared to adults, children and adolescents of the community more frequently report clinical high risk of psychosis (CHR) criteria. Yet, little is known about the prevalence of CHR criteria in clinical children and adolescents’ samples. Thus, we studied the prevalence of CHR criteria and symptoms in 8- to 17-year-old inpatients with disorders that have been associated with greater odds to develop psychosis in adulthood, i.e., attention-deficit hyperactivity disorder, social and specific phobia, and obsessive-compulsive disorder, eating disorders and Asperger’s disorder. METHODS: As part of the multicenter naturalistic Bi-national Evaluation of At-Risk Symptoms in children and adolescents (BEARS-Kid) study, 8- to 17-year-olds of the community (N=235) and 8- to 17-year-old inpatients with any one of the above main diagnoses who were not suspected to be at increased risk of psychosis (N=306) were examined for CHR symptoms and criteria with the Schizophrenia Proneness Instrument, Child & Youth version and with the Structured Interview for Psychosis-Risk Syndromes. RESULTS: At 6.4%, the prevalence rate of CHR criteria in the community sample did not significantly differ from the 8.2%-rate in the inpatient sample. CHR criteria and symptoms were generally associated with age but not with group membership. DISCUSSION: This indicates that, irrespective of their mental health status, children and adolescents present more frequently with CHR criteria compared to young adults of the community for whom a 2.4%-rate of CHR criteria had earlier been reported. Furthermore, these findings contradict assumptions that CHR criteria might be diagnostically puripotential or merely severity markers of mental illness. Yet, more research into these symptoms and their cause and meaning in children and adolescents is needed to understand their significance in this age group and to detect factors that convey their clinical relevance in adulthood.
format Online
Article
Text
id pubmed-7233916
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72339162020-05-23 O10.5. CLINICAL HIGH RISK (CHR) CRITERIA IN CHILDREN AND ADOLESCENTS NOT SUSPECTED TO DEVELOP PSYCHOSIS: NO TRANSDIAGNOSTIC SEVERITY MARKER OF MENTAL HEALTH PROBLEMS Schultze-Lutter, Frauke Michel, Chantal Schimmelmann, Benno G Franscini, Maurizia Traber-Walker, Nina Walger, Petra Schizophr Bull Oral Session: Digital Health/Methods BACKGROUND: Compared to adults, children and adolescents of the community more frequently report clinical high risk of psychosis (CHR) criteria. Yet, little is known about the prevalence of CHR criteria in clinical children and adolescents’ samples. Thus, we studied the prevalence of CHR criteria and symptoms in 8- to 17-year-old inpatients with disorders that have been associated with greater odds to develop psychosis in adulthood, i.e., attention-deficit hyperactivity disorder, social and specific phobia, and obsessive-compulsive disorder, eating disorders and Asperger’s disorder. METHODS: As part of the multicenter naturalistic Bi-national Evaluation of At-Risk Symptoms in children and adolescents (BEARS-Kid) study, 8- to 17-year-olds of the community (N=235) and 8- to 17-year-old inpatients with any one of the above main diagnoses who were not suspected to be at increased risk of psychosis (N=306) were examined for CHR symptoms and criteria with the Schizophrenia Proneness Instrument, Child & Youth version and with the Structured Interview for Psychosis-Risk Syndromes. RESULTS: At 6.4%, the prevalence rate of CHR criteria in the community sample did not significantly differ from the 8.2%-rate in the inpatient sample. CHR criteria and symptoms were generally associated with age but not with group membership. DISCUSSION: This indicates that, irrespective of their mental health status, children and adolescents present more frequently with CHR criteria compared to young adults of the community for whom a 2.4%-rate of CHR criteria had earlier been reported. Furthermore, these findings contradict assumptions that CHR criteria might be diagnostically puripotential or merely severity markers of mental illness. Yet, more research into these symptoms and their cause and meaning in children and adolescents is needed to understand their significance in this age group and to detect factors that convey their clinical relevance in adulthood. Oxford University Press 2020-05 2020-05-18 /pmc/articles/PMC7233916/ http://dx.doi.org/10.1093/schbul/sbaa028.059 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Oral Session: Digital Health/Methods
Schultze-Lutter, Frauke
Michel, Chantal
Schimmelmann, Benno G
Franscini, Maurizia
Traber-Walker, Nina
Walger, Petra
O10.5. CLINICAL HIGH RISK (CHR) CRITERIA IN CHILDREN AND ADOLESCENTS NOT SUSPECTED TO DEVELOP PSYCHOSIS: NO TRANSDIAGNOSTIC SEVERITY MARKER OF MENTAL HEALTH PROBLEMS
title O10.5. CLINICAL HIGH RISK (CHR) CRITERIA IN CHILDREN AND ADOLESCENTS NOT SUSPECTED TO DEVELOP PSYCHOSIS: NO TRANSDIAGNOSTIC SEVERITY MARKER OF MENTAL HEALTH PROBLEMS
title_full O10.5. CLINICAL HIGH RISK (CHR) CRITERIA IN CHILDREN AND ADOLESCENTS NOT SUSPECTED TO DEVELOP PSYCHOSIS: NO TRANSDIAGNOSTIC SEVERITY MARKER OF MENTAL HEALTH PROBLEMS
title_fullStr O10.5. CLINICAL HIGH RISK (CHR) CRITERIA IN CHILDREN AND ADOLESCENTS NOT SUSPECTED TO DEVELOP PSYCHOSIS: NO TRANSDIAGNOSTIC SEVERITY MARKER OF MENTAL HEALTH PROBLEMS
title_full_unstemmed O10.5. CLINICAL HIGH RISK (CHR) CRITERIA IN CHILDREN AND ADOLESCENTS NOT SUSPECTED TO DEVELOP PSYCHOSIS: NO TRANSDIAGNOSTIC SEVERITY MARKER OF MENTAL HEALTH PROBLEMS
title_short O10.5. CLINICAL HIGH RISK (CHR) CRITERIA IN CHILDREN AND ADOLESCENTS NOT SUSPECTED TO DEVELOP PSYCHOSIS: NO TRANSDIAGNOSTIC SEVERITY MARKER OF MENTAL HEALTH PROBLEMS
title_sort o10.5. clinical high risk (chr) criteria in children and adolescents not suspected to develop psychosis: no transdiagnostic severity marker of mental health problems
topic Oral Session: Digital Health/Methods
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233916/
http://dx.doi.org/10.1093/schbul/sbaa028.059
work_keys_str_mv AT schultzelutterfrauke o105clinicalhighriskchrcriteriainchildrenandadolescentsnotsuspectedtodeveloppsychosisnotransdiagnosticseveritymarkerofmentalhealthproblems
AT michelchantal o105clinicalhighriskchrcriteriainchildrenandadolescentsnotsuspectedtodeveloppsychosisnotransdiagnosticseveritymarkerofmentalhealthproblems
AT schimmelmannbennog o105clinicalhighriskchrcriteriainchildrenandadolescentsnotsuspectedtodeveloppsychosisnotransdiagnosticseveritymarkerofmentalhealthproblems
AT franscinimaurizia o105clinicalhighriskchrcriteriainchildrenandadolescentsnotsuspectedtodeveloppsychosisnotransdiagnosticseveritymarkerofmentalhealthproblems
AT traberwalkernina o105clinicalhighriskchrcriteriainchildrenandadolescentsnotsuspectedtodeveloppsychosisnotransdiagnosticseveritymarkerofmentalhealthproblems
AT walgerpetra o105clinicalhighriskchrcriteriainchildrenandadolescentsnotsuspectedtodeveloppsychosisnotransdiagnosticseveritymarkerofmentalhealthproblems